SAILIFE
Sai Life Sciences Limited (SAILIFE) Stock Analysis
Sai Life Sciences Limited provides contract research, development, and manufacturing services to pharmaceutical and biotech clients. It offers discovery chemistry, API development, and formulation manufacturing from facilities in India. The company supports innovators and generics with integrated CDMO capabilities. It is listed on Indian stock exchanges.
Healthcare › Diagnostics & Research
₹1,389.40
-6.62% 1W | +60.00% 52W
Market Cap
29.5k CR
P/E Ratio
82.1
52W High
₹1697
52W Low
₹783.9
Div. Yield
0%
Beta
–
50 DMA
₹1517.8
200 DMA
₹1179.9
Profit Margin
16.1%
Inst. Own.
43.2%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 384 | 439 | 280 | 396 | 440 | 580 | 496 | 537 | 556 | 602 | 554 |
| Expenses | 287 | 315 | 254 | 293 | 320 | 422 | 375 | 392 | 369 | 426 | 406 |
| Operating Profit | 96 | 125 | 26 | 102 | 120 | 158 | 121 | 146 | 188 | 177 | 148 |
| OPM % | 25% | 28% | 9% | 26% | 27% | 27% | 24% | 27% | 34% | 29% | 27% |
| Other Income | 11 | 3 | 8 | 10 | 9 | 10 | 10 | 15 | 0 | 16 | 4 |
| Interest | 23 | 21 | 21 | 21 | 23 | 11 | 12 | 9 | 10 | 8 | 8 |
| Depreciation | 31 | 31 | 31 | 36 | 34 | 37 | 38 | 40 | 44 | 45 | 46 |
| Profit before tax | 53 | 76 | -18 | 55 | 72 | 119 | 81 | 112 | 134 | 139 | 98 |
| Tax % | 25% | 26% | -25% | 25% | 25% | 26% | 25% | 25% | 25% | 25% | 25% |
| Net Profit | 40 | 56 | -14 | 42 | 54 | 88 | 60 | 84 | 100 | 104 | 73 |
| EPS in Rs | 2.59 | 4.24 | 2.90 | 4.00 | 4.75 | 4.92 | 3.45 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 695 | 726 | 760 | 870 | 1,217 | 1,465 | 1,695 | 2,192 | 2,250 |
| Expenses | 520 | 558 | 593 | 743 | 1,048 | 1,178 | 1,285 | 1,559 | 1,592 |
| Operating Profit | 176 | 168 | 167 | 126 | 169 | 287 | 410 | 634 | 658 |
| OPM % | 25% | 23% | 22% | 15% | 14% | 20% | 24% | 29% | 29% |
| Other Income | 6 | 18 | 27 | 28 | 27 | 29 | 35 | 40 | 35 |
| Interest | 24 | 22 | 33 | 54 | 81 | 88 | 78 | 41 | 35 |
| Depreciation | 44 | 55 | 80 | 90 | 99 | 119 | 139 | 167 | 175 |
| Profit before tax | 113 | 109 | 82 | 10 | 16 | 109 | 228 | 466 | 483 |
| Tax % | 35% | 30% | 25% | 36% | 39% | 24% | 25% | 25% | |
| Net Profit | 73 | 76 | 61 | 6 | 10 | 83 | 170 | 349 | 362 |
| EPS in Rs | 8.16 | 16.48 | 17.12 | ||||||
| Dividend Payout % | 0% | 0% | 0% | 1,117% | 676% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 22.0% | 24.0% | – |
| Profit CAGR | 227.0% | 42.0% | – |
Shareholding Pattern
Promoters34.95%
FIIs22.50%
DIIs29.92%
Public12.65%
Promoters34.70%
FIIs21.41%
DIIs31.41%
Public12.49%
Promoters34.61%
FIIs21.17%
DIIs31.54%
Public12.69%
Promoters34.53%
FIIs19.65%
DIIs32.71%
Public13.11%
Promoters34.50%
FIIs19.91%
DIIs32.32%
Public13.25%
Promoters35.16%
FIIs12.36%
DIIs13.26%
Public39.21%
Promoters34.61%
FIIs21.17%
DIIs31.54%
Public12.69%
Promoters34.50%
FIIs19.91%
DIIs32.32%
Public13.25%
SAILIFE
Holdings Analysis
Key strengths & risk signals
70
Overall
74
Fundamental
67
Technical
Risks (3)
TOO MUCH PUBLIC HOLDING! 41.08% public ownership - higher volatility risk.
RECOVERY MODE! Current price (1389.4) above 200-day but below 50-day.
WEAK MOMENTUM! Limited price growth - -6.6% (1 week), -9.7% (1 month), 9.2% (3 months).
Strengths (4)
UNDERVALUED! PEG of 0.36 indicates stock is cheap relative to growth.
BULLISH TREND! 50-day average (1517.8) is above 200-day average (1179.9) - positive signal.
EXCELLENT YEAR! Stock gained 60.0% in the last year.
APPROACHING OVERSOLD! RSI at 31.4 - watch for reversal.
Fundamental & Technical Analysis
70Overall
74Fundamental
67Technical
Fundamental Breakdown
Growth Quality
30/30
Revenue CAGR: 21.3% (EXCELLENT, 15/15). Profit CAGR: 226.9% (EXCELLENT, 15/15).
Profit Margin
6/10
GOOD EFFICIENCY! 16.1% profit margin - above average profitability.
PEG Valuation
10/10
UNDERVALUED! PEG of 0.36 indicates stock is cheap relative to growth.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.17 - excellent financial health.
Public Holding
5/20
TOO MUCH PUBLIC HOLDING! 41.08% public ownership - higher volatility risk.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (1517.8) is above 200-day average (1179.9) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (1389.4) above 200-day but below 50-day.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
10/10
EXCELLENT YEAR! Stock gained 60.0% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 10 up days, 20 down days. Avg volume on up days: 677,344 vs down days: 597,396. Ratio: 1.13x
RSI
4/5
APPROACHING OVERSOLD! RSI at 31.4 - watch for reversal.
52W Range
4/5
UPPER HALF! Trading at 66.3% of 52W range - positive territory.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -6.6% (1 week), -9.7% (1 month), 9.2% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
SAILIFE
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-12 | Concall PDF |
Peer Comparison
Healthcare · Diagnostics & Research · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SAILIFE | ₹1,389.40 | 82.1 | 16.1% | 21.3% | 226.9% | +60.0% | 70 | BREAKDOWN | +21.2% | -29.7% | +11.7% | -7.9% |
| LALPATHLAB | ₹1,859.90 | 57.4 | 18.7% | 11.1% | 28.3% | +24.7% | 87 | BREAKDOWN | +28.0% | +29.1% | +19.1% | +13.5% |
| SYNGENE | ₹386.10 | 70.3 | 6.1% | 5.4% | -12.0% | -40.0% | 57 | BOUNCE FROM SUPPORT | -110.4% | -106.1% | -15.8% | -29.0% |
| VIJAYA | ₹1,381.70 | 76 | 21.9% | 21.0% | 26.9% | +41.3% | 74 | BREAKDOWN | +37.6% | +10.9% | +22.8% | +5.3% |
| METROPOLIS | ₹530.40 | 54.6 | 11.8% | 12.8% | 10.0% | +7.9% | 67 | BREAKDOWN | +25.7% | +11.4% | +16.6% | +6.0% |
| THYROCARE | ₹485.20 | 44 | 20.1% | 16.7% | 36.2% | +17.6% | 87 | BREAKDOWN | +34.2% | +10.8% | +24.4% | +7.1% |
| VIMTALABS | ₹522.50 | 29.6 | 18.9% | 8.9% | 17.2% | -21.8% | 57 | BREAKDOWN | +11.1% | -0.5% | +11.8% | -0.1% |
| KRSNAA | ₹533.30 | 18 | 11.6% | 16.6% | 17.8% | -32.4% | 61 | APPROACHING SUPPORT | -19.0% | -60.2% | +22.0% | +22.3% |
Data from TradeAlone · Updated daily
SAILIFE News
Sai Life Sciences Limited (NSE: SAILIFE) clears resistance, gains 5% intraday2026-08-10Sai Life Sciences Limited (sailife) Q1 FY27: Revenue Up 12% Yoy, Strong CRO Growth2026-08-07Sai Life Sciences Limited (sailife) FY26 Results: Revenue and Profitability Surge2026-05-15Sai Life Sciences Becomes First Indian CRDMO With Renewable Energy Site2026-05-11
